Respiratory syncytial virus (RSV), the most important cause of lower respiratory disease in infants and young children, is rarely considered among the causes for community-acquired lower respiratory infection in adults. All noninstitutionalized adults hospitalized with community-acquired pneumonia in two Ohio counties were evaluated between December 1990 and May 1992. Fifty-three (4.4%) of 1195 adults admitted during the RSV seasons and 4 (1.0%) of 390 in the off-season had serologic evidence of RSV infection, making RSV one of the four most common pathogens identified. RSVinfected patients had clinical features (e.g., wheezing and rhonchi) that distinguished them from all non-RSV-infected patients and other features (e.g., nonelevated white blood cell counts) that distinguished them from those infected with bacterial or atypical agents. However, RSV infection was not diagnosed during hospitalization for any of the 57 RSV-infected patients. RSV should be considered in the differential diagnosis for adults hospitalized between November and April with community-acquired lower respiratory infection.
characteristics and importance of RSV infections in this population of hospitalized adults.
Methods
Patients and study design. All eligible patients hospitalized at any of the 15 adult care hospitals in Franklin or Summit counties in Ohio between 15 December 1990 and 31 May 1992 were enrolled in the community-based pneumonia incidence study (CBPIS) [30] . Eligible patients were residents of one of the two counties, had an admitting clinical diagnosis of pneumonia, werẽ 18 years of age, were not residents of institutions (nursing homes, other chronic care facilities, or prisons), and had not been discharged from a hospital within 30 days preceding hospital admission.
Information on underlying medical conditions, clinical and radiographic presentation, and hospital course was abstracted from hospital charts of all patients. Patients who consented were interviewed using a standardized form and had specimens of urine, sputum, and serum collected soon after admission. These patients were recontacted after 4-6 weeks for a follow-up questionnaire and a convalescent-phase serum sample. Only patients from the CBPIS with both acute-and convalescent-phase samples available were eligible for the present study.
Results of blood and sputum cultures and of sputum Gram's stain were abstracted from medical records; these tests were done at the discretion of clinicians. Serum specimens were tested systematically for antibodies to Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydia pneumoniae at the Centers for Disease Control and Prevention. In addition, all serum specimens from patients hospitalized between October and April were tested for antibodies to influenza virus types A and B. Definite diagnosis of other bacterial causes for pneumonia required positive blood or pleural fluid cultures. Details of testing procedures and criteria for , as defined by laboratory-based surveillance system [31] (no. of reported isolations or detections of RSV in national surveillance; defined before testing in present study), and their relationships to RSV infection rates among adults hospitalized for lower respiratory tract infection in 2 Ohio counties during same period (bottom).
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defining infection with specific etiologic agents have been described [30] .
RSV diagnostic testing. We tested all paired acute-and convalescent-phase sera from patients admitted during RSV seasons and a 30% sample of paired sera from patients admitted during other times of the year for RSV antibodies. The RSV seasons were defined on the basis of surveillance data from the US laboratorybased respiratory and enteric viruses surveillance system, using information for the east north central census division, which includes Ohio (see figure 1 ) [31] .
Specific serum IgG antibodies to RSV were measured by an indirect EIA modified from standard methods [32] , using a pooled cell lysate from HEp-2 cells infected with RSV strains A2 and 18537. Paired acute-and convalescent-phase specimens were tested at a single screening dilution in parallel, and those pairs with a ratio of convalescent signal to acute signal of at least 1.5 were tested for ;~:4-fold rises in antibody titer by serial 2-fold dilution. All specimens were tested against uninfected cells to ensure the specificity of the test.
All persons with significant IgG rises or with significantly elevated IgG levels in the acute-phase specimen (optical density units > 1.0), and a random sample of 105 persons with no serologic evidence for recent RSV infection, were tested for RSV-specific IgM antibodies. The assay for IgM antibodies was done as described above for IgG, after precipitation of IgG antibodies using an inactivation reagent (GullSORB; Gull Laboratories, Salt Lake City). IgM antibodies were identified if the specimen absorbance was~5 SD above the mean of a panel of 10 IgM-negative sera.
For the rest of the analysis, RSV -infected patients were defined as those with~4-fold rises in RSV -specific IgG antibodies.
Statistical analysis. RSV -infected patients were first compared with 3 other groups of patients: those infected with influenza viruses, those with "typical" bacterial agents (Streptococcus pneumoniae, Haemophilus injiuenzae, Streptococcus pyogenes, Neisseria meningitidis, Staphylococcus aureus, Escherichia coli, and Klebsiella species), and those with "atypical" bacterial agents (L. pneumophila, M. pneumoniae, and C. pneumoniae), using X 2 tests for categorical variables and Wilcoxon rank sum tests for continuous variables. Comparison was done separately for typical and atypical bacteria because this has been a traditional distinction and the clinical features were sufficiently different to warrant considering them separately.
RSV-infected patients were also compared with all RSV -uninfected patients in a similar manner. Those variables found to be different in the 2 groups (P < .2) and those thought to be potentially important predictors of RSV status based on existing literature were analyzed further using stratified analysis (Mantel-Haenszel X 2 and multiple logistic regression modeling) to control for confounding and assess for interaction. Combinations of those variables that were independent predictors of RSV infection were then assessed to determine the feasibility of identifying patients particularly likely to be RSV -infected on a clinical basis.
Results
Prevalence ofRSV infection. A total of 1585 pairs of serum specimens were tested for RSV IgG antibodies, including speci-mens from 1195 (97%) of the 1232 patients admitted during one of the two RSV seasons and from 390 (29%) of the 1357 patients admitted during the two off-seasons. Of the 1585 patients tested, 57 (3.6%) had a~4-fo1d rise in IgG titer; 53 (4.4%) were from the RSV seasons and 4 (1.0%) were from the off-seasons. The rates for the individual seasons varied from 0 (off-season, 1992) to 5.4% (RSV season, 1991 (RSV season, -1992 , and the timing of the RSV infections was as expected on the basis of data from the laboratory-based RSV surveillance system (figure 1). Of the 57 serum pairs with a significant rise in IgG titers, 33 (58%) also had detectable RSV-specific IgM antibodies in acute-phase sera, as did 15 (19%) of 78 with high acute IgG titers but no significant rise in titer and 1 (1%) of the 105 randomly selected IgG-negative samples.
In these 1195 adults with community-acquired pneumonia admitted during RSV season, the four most commonly identified pathogens were S. pneumoniae (6.2%), influenza virus types A and B (5.4%), RSV (4.4%), and M pneumoniae (4.1%). If those with extremely high IgG levels and IgM positive for RSV were included (15 patients), the rate of RSV infection would be 5.9%. In this study we counted "definite" infections but not "probable" or "possible" infections; by these strict criteria, only 21% of the patients had a specific etiologic agent identified [30] .
Eight (14%) RSV-infected patients had one or more other pathogens identified. These included influenza A virus (2), S. pneumoniae (2), M pneumoniae (2), influenza B virus (1), and S. pyogenes (1) . This rate of dual infections was similar to that for dual infections among those with other pneumonia pathogens identified (13%).
Clinical presentation. The ages of the 57 RSV-infected patients ranged from 21 to 98 years (mean, 61), similar to the 1528 patients with pneumonia who were not RSV-infected (range, 18-98 years; mean, 61). RSV-infected patients were somewhat more likely than those with bacterial or atypical pneumonia to be >60 years old (table 1), but the mean ages of the groups did not differ significantly (P > .05, data not shown).
The proportion with RSV infection by 10-year age group are shown in table 2. The 8 patients between the ages of 18 and 39 who were RSV-infected were previously healthy young adults with no history of diabetes, emphysema/chronic bronchitis, or asthma; 1 had coronary artery disease and 4 were smokers. They had clinical presentations similar to the other RSVinfected patients, as described below; 7 presented with wheezing on examination or by report, and none had an elevated white blood cell (WBC) count.
Some other pre-illness characteristics of the 57 RSV-infected patients differed from patients with other types of pneumonia (table 1) . Those with RSV infections were more likely to have underlying cardiopulmonary conditions such as congestive heart failure, emphysema/chronic bronchitis, or asthma than those with influenza virus or bacterial or atypical pneumonia. They were also more likely to report exposure to someone with a cough or cold in the preceding 4 weeks. These observations also applied when RSV-infected patients were compared with all RSV-negative pneumonia patients, although the differences tended to be less distinct.
RSV-infected patients also presented with a clinical picture that was different from that of the patients with other types of pneumonia (table 3) . Compared with those with bacterial pneumonia, they were more likely to have cough, runny nose, and a nonelevated WBC count and less likely to have fever. Compared with those with atypical pneumonia, they were less likely to have crackles on physical examination or to have a chest radiograph read as pneumonia. Importantly, 40% of those with RSV infection had pneumonia or consolidation on chest radiograph, and in 35% of chest radiographs, the distribution was read as lobar. However, the clinical features that most clearly separated the RSV -infected patients from each of the other 4 groups of pneumonia patients were the presence of wheezing by history or physical examination and rhonchi on physical examination.
After stratifying to control for associations with other variables, including asthma, emphysema/chronic bronchitis, and others (see Methods), three variables remained independently associated with RSV infection by comparison with the overall group: admission during RSV season (P = .007), rhonchi on examination (P = .009), and wheezing by examination or report (P = .002). A nonelevated WBC count remained of borderline significance (P = .09).
For patients admitted during one of the RSV seasons, those clinical findings and preexisting illnesses found to be independently associated with RSV could be combined to define groups of patients with further increased probability of RSV infection (table 4) . Patients with combinations of certain clinical findings had elevated rates of RSV infection, and those with underlying conditions as well as the above combinations of clinical findings had the highest rates. There were 123 patients with neither an underlying condition nor one of the three clinical findings; none showed evidence of RSV infection.
Among those infected with RSV, the mean length of stay was 9 days, 72% required supplemental oxygen, 21% required intensive care, and 7% were intubated. Mortality rates could not be assessed, since those patients who died would have been excluded from our sample because they would not have provided convalescent-phase sera. Although for the overall group these outcomes did not differ from those for the RSVuninfected patients, some differences were found among subgroups. Among patients < 60 years of age, those who were RSV -infected were less likely than those who were RSV -negative to require supplemental oxygen (56% vs. 77%, P = .04), whereas among the older patients, the rates were 79% and 82%, respectively (P = .68). Among patients without asthma, the length of stay was slightly shorter for the RSV-infected group (8.4 vs. 9.5 days, P = .21); however, for those with asthma the effect was opposite, with RSV-infected patients requiring longer stays (10.2 vs. 8.6 days, P = .02). None of the patients were diagnosed with RSV at the time of hospitalization. One of the 53 had a discharge diagnosis of viral pneumonia; the rest had a variety of diagnoses, including pneumonia (17), chronic obstructive pulmonary disease (6), respiratory failure (4), bronchopneumonia (2), emphysema (2), and others. If discharge diagnoses were grouped into those with bronchial disease (i.e., acute bronchitis, bronchopneumonia, chronic bronchitis, asthma, or chronic obstructive pulmonary disease) and those with pneumonia (i.e., pneumonia and pneumonia with a specified bacterial agent), RSV -infected patients were more likely to have been diagnosed with bronchial disease than were RSV-uninfected patients (31% vs. 17%, P = .03). 
Discussion
In this population-based study, RSV was among the four leading pathogens identified after systematic testing of adults hospitalized with lower respiratory tract infection during the RSV season, but this infection was not diagnosed at the time of hospitalization in any of the patients.
The common impression that RSV does not cause serious illness in adults may originate from several studies in the early 1960s that demonstrated that RSV infection of a small number of healthy young prisoner volunteers and military recruits resulted in only mild illness [4, 33, 34] . However, even such apparently mild infections in healthy adults can lead to lower respiratory tract changes, as demonstrated by pulmonary function studies of previously healthy young adults who had increased airway resistance and reactivity for 8 weeks following infection [3] .
That RSV can cause severe lower respiratory tract disease in immunocompromised adult patients and the institutionalized elderly is now well recognized [5 -16] . In addition, there are case reports of community-acquired RSV infection causing pneumonia and respiratory failure in previously healthy elderly adults [17, 18, 27] . Furthermore, three hospital-based studies from Europe have reported rates of RSV infection among elderly patients admitted with acute lower respiratory tract disease ranging from 3% to 8%, as assessed by significant rises in RSV antibody titers [20, 21, 25] . A recent study found RSV to be as important as influenza virus among community-dwelling elderly persons admitted between November and April with influenza-like illness [22] . RSV antibody titer rises have also been demonstrated in middle-aged adults with acute exacerbations of chronic bronchitis, for whom RSV has been the major pathogen identified in some studies [28, 29] . Finally, RSV has been identified in respiratory secretions of adult patients with pneumonia in general medical wards [24, 25] and in institutionalized young adults [23] .
We believe that the 57 patients with significant titer rises in this study were truly RSV -infected, The infections occurred with a distinct seasonal pattern, which corresponded to the pattern we expected on the basis of the laboratory surveillance of RSV detections in the US east north central census division. There is ample previous evidence correlating 4-fold rises in RSV antibodies to viral shedding, beginning with a study of 41 volunteers in 1961 and confirmed in more recent investigations [22, 33] . In addition, the IgG rises were accompanied by RSV-specific IgM in 58% of cases, similar to the rate of IgM detection among those with 4-fold complement-fixing antibody titer rises in earlier reports [35] . In fact, requiring significant rises in IgG antibody titers is probably an insensitive method to detect RSV infections in adults. Many adults have high existing levels of RSV -specific IgG, and some of these may not mount a further rise in antibody on reinfection [10, 20, 36] . Seventy-eight patients in our sample had very high IgG levels on the acute-phase serum sample, and IgM antibodies were present in 19% of these samples; however, we chose not to consider these infections to be related to the hospitalization, since it remained possible that they occurred weeks before admission. Even adults without high preexisting antibody levels may be infected and fail to mount a significant antibody rise as assessed by complement fixation testing [25] . The 57 patients we identified, therefore, provide a minimum estimate, and the true proportion of adults hospitalized with lower respiratory tract infection and RSV infection is likely to be higher.
RSV is known to be a major nosocomial pathogen in pediatric hospitals. Therefore, an important consideration in this study was whether the RSV infections precipitated the hospitalization or occurred as a result of it. We believe that most of these RSV infections were community-acquired rather than hospitalacquired. Thirty-six percent of patients already had IgM present in the acute-phase serum specimen drawn within 48 h of admission, and RSV IgM antibodies in adults are not reliably detected until 1-2 weeks after onset of disease [37, 38] . The fact that the rate of other pathogens isolated was lower in the RSVinfected group than in the overall group provides further evidence that RSV infection led to hospitalization. This evidence suggests that the RSV infections occurred before hospitalization and, in fact, precipitated hospitalization for at least some of the patients.
We were surprised to find that the proportion of all lower respiratory infections caused by RSV was similar among younger and elderly patients. There was a trend for the groups with RSV and influenza virus pneumonia to be older than those with bacterial or atypical pathogens, but the differences in the ages among the various groups was not substantial. Notably, the 8 RSV-infected patients between the ages of 18 and 39 were previously healthy young adults. It may be that on a population basis the elderly are at increased risk for severe RSV disease, but since they are also more likely to be hospitalized for all other pneumonias, the likelihood of RSV infection in a patient hospitalized with pneumonia does not change with the age of the patient.
Although we cannot unequivocally link RSV infections to the lower respiratory disease in these patients in the absence of pathologic specimens, the clinical characteristics and lack of another pathogen in 86% of the RSV -infected patients suggest that RSV caused the disease. Patients with RSV infections had clinical presentations that differed from all RSV -uninfected pneumonia patients, were even more distinct than those from patients with bacterial pneumonia, and were also distinct from those with influenza virus or atypical pneumonia. These clinical features were consistent with the expected clinical manifestations of RSV infection: upper respiratory symptoms after exposure to someone with a cough or cold and, in severe cases, acute obstructive airway disease with wheezing and rhonchi, and lower WBC counts than those observed with typical bacterial pneumonia [1] .
These clinical findings should alert the clinician to consider RSV as a cause of pneumonia in adult patients. On the basis of the findings from this study, patients hospitalized with lower respiratory infection during the RSV season (usually November to April) who present with wheezing, rhonchi, or a normal WBC count, as well as those with asthma or emphysema/ chronic bronchitis, have an increased likelihood of RSV infection. Patients admitted outside of the RSV season, or those admitted during RSV season without an underlying pulmonary condition, who have an elevated WBC count and no wheeze or rhonchi on examination, are very unlikely to be infected with RSV.
Detecting RSV -infected adults at hospital admission is important for patient management. Because RSV can cause devastating disease in immunocompromised patients and is a wellknown nosocomial pathogen, early identification of RSV-infected patients is necessary for infection-control purposes, especially in hospitals with bone-marrow transplant wards or patients with AIDS. Furthermore, fulminating disease can occur in previously healthy elderly patients and in those with compromised immune systems. In addition, early therapy with ribavirin has decreased morbidity and mortality in adult case series and uncontrolled trials [16, 17, 39] . Therefore, RSV should be included in the differential diagnosis for all adults hospitalized between November and April with communityacquired lower respiratory tract disease.
